Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Persistence of Protection by Shingrix [Phase 4]
Phase 4 trial updates show persistence of protection from Shingrix against herpes zoster; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults [Phase 3]
This long-term follow-up analysis from two Phase 3 studies evaluates the durability of efficacy, safety, and immunogenicity of GSK's Herpes …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine [Phase 1]
A first-in-human Phase 1 study of JCXH-105, an srRNA-based vaccine for herpes zoster (shingles), has completed its Phase 1 evaluation.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years [Phase 4]
Phase 4 trial evaluating efficacy, immunogenicity, and safety of Shingrix in Chinese adults aged 50 and older; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT [Phase 4]
Phase 4 double-blind, placebo-controlled randomized trial evaluating Shingrix in patients with rheumatic diseases; the study is not yet recr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Simultaneous RZV and aIIV4 Vaccination [Phase 4]
Phase 4 trial by Duke University evaluating simultaneous administration of the recombinant zoster vaccine with an adjuvanted quadrivalent in…
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India [Phase 3]
Phase 3 trial in adults aged 50 years and older in India evaluating the immune response and safety of a herpes zoster vaccine; results have …
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults [Phase 3]
A Phase 3 trial update assessing long-term efficacy, safety, and persistence of immune response for a herpes zoster vaccine in older adults.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster [Phase 2]
Phase 2 trial evaluating peginterferon for herpes zoster has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years [Phase 1, Phase 2]
Clinical trial update on a zoster vaccine in healthy adults aged 40 and older (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response [Phase 3]
A Phase 3 trial by GlaxoSmithKline evaluated the long-term immune response to its herpes zoster subunit vaccine in adults who had kidney tra…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine [Phase 3]
Phase 3 trial evaluating immune response and safety when shingles vaccine and influenza vaccine are given together or after a COVID-19 boost…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine [Phase 3]
Phase 3 clinical study evaluating protective efficacy and safety of a recombinant herpes zoster vaccine is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: NPC-06 to Pain Associated With Acute Herpes Zoster [Phase 3]
Phase 3 clinical trial update for NPC-06 addressing pain associated with acute herpes zoster has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) [Phase 2]
A Phase 2 trial examining age-related differences in immune responses to influenza and herpes zoster vaccines (INFLUENZA-SHINGRIX) has compl…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer [Phase 3]
A Phase 3 non-inferiority trial evaluating ZK-A03 for herpes zoster following an alteration of the active ingredient manufacturer; current s…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Study on Efficacy of Attenuated Zoster Vaccine, Live [Phase 3]
Phase 3 clinical trial evaluating the efficacy of an attenuated live zoster vaccine for herpes zoster has been completed.
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster [Phase 4]
Phase 4 trial update assessing efficacy and safety of foscarnet sodium and sodium chloride injection in patients with herpes zoster.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age [Phase 3]
Phase 3 efficacy trial of a vaccine to prevent herpes zoster in adults over 40 has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of GSK's herpes zoster vaccine co-administered with Prevnar13 in adults 50+ years; study …
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia [Phase 4]
Phase 4 trial update on pregabalin for treating acute herpetic neuralgia related to herpes zoster.
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy
A completed clinical trial study estimating the burden of herpes zoster and post-herpetic neuralgia in Italy; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022
A completed clinical trial assessing frailty in subjects during ZOSTER-006 and ZOSTER-022.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies. [Phase 3]
Phase 3 trial update for cross-vaccination of the GSK herpes zoster subunit vaccine in adults who previously received placebo, with results …
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients [Phase 4]
Phase 4 clinical trial update evaluating safety and tolerability of a herpes zoster vaccine in rheumatologic patients.